Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 Oct;27(10):2208–2213. doi: 10.1128/jcm.27.10.2208-2213.1989

Identification of pseudorabies virus-exposed swine with a gI glycoprotein enzyme-linked immunosorbent assay.

M W Mellencamp 1, N E Pfeiffer 1, B T Suiter 1, J R Harness 1, W H Beckenhauer 1
PMCID: PMC266995  PMID: 2555390

Abstract

A monoclonal antibody specific for the gI glycoprotein of virulent pseudorabies virus was produced and used to affinity purify gI glycoprotein. The purified gI was used in an enzyme-linked immunosorbent assay (ELISA) that identified and differentiated field virus-exposed animals from animals vaccinated with gI-deleted virus. The gI ELISA was evaluated by comparing it with the virus neutralization test and with a standard ELISA which does not distinguish between vaccinated and naturally infected animals. Pigs vaccinated with a gI-deleted vaccine were seropositive by the virus neutralization or standard ELISA but were seronegative in the gI ELISA. Nonvaccinated and vaccinated animals were detected as seropositive in the gI ELISA only after exposure to gI-containing field virus. Exposed animals were detected as early as day 7 and for as long as 141 days after field virus exposure. As little as 10(2.7) PFU of field virus was sufficient to seroconvert negative animals in the gI ELISA. Pseudorabies virus-seronegative animals which received multiple doses of gI-deleted vaccine remained seronegative in the gI ELISA. The use of this test to monitor swine for pseudorabies virus infection would offer significant benefits towards eradication of the disease.

Full text

PDF
2208

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belák S., Linné T. Rapid detection of Aujeszky's disease (pseudorabies) virus infection of pigs by direct filter hybridisation of nasal and tonsillar specimens. Res Vet Sci. 1988 May;44(3):303–308. [PubMed] [Google Scholar]
  2. Ben-Porat T., DeMarchi J. M., Lomniczi B., Kaplan A. S. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies. Virology. 1986 Oct 30;154(2):325–334. doi: 10.1016/0042-6822(86)90458-7. [DOI] [PubMed] [Google Scholar]
  3. Ben-Porat T., DeMarchi J., Pendrys J., Veach R. A., Kaplan A. S. Proteins specified by the short unique region of the genome of pseudorabies virus play a role in the release of virions from certain cells. J Virol. 1986 Jan;57(1):191–196. doi: 10.1128/jvi.57.1.191-196.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  5. Eloit M., Fargeaud D., L'Haridon R., Toma B. Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies. Arch Virol. 1988;99(1-2):45–56. doi: 10.1007/BF01311022. [DOI] [PubMed] [Google Scholar]
  6. Hampl H., Ben-Porat T., Ehrlicher L., Habermehl K. O., Kaplan A. S. Characterization of the envelope proteins of pseudorabies virus. J Virol. 1984 Nov;52(2):583–590. doi: 10.1128/jvi.52.2.583-590.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ishii H., Kobayashi Y., Kuroki M., Kodama Y. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI. J Gen Virol. 1988 Jun;69(Pt 6):1411–1414. doi: 10.1099/0022-1317-69-6-1411. [DOI] [PubMed] [Google Scholar]
  8. Kit S., Sheppard M., Ichimura H., Kit M. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes. Am J Vet Res. 1987 May;48(5):780–793. [PubMed] [Google Scholar]
  9. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  10. Lomniczi B., Blankenship M. L., Ben-Porat T. Deletions in the genomes of pseudorabies virus vaccine strains and existence of four isomers of the genomes. J Virol. 1984 Mar;49(3):970–979. doi: 10.1128/jvi.49.3.970-979.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lukàcs N., Thiel H. J., Mettenleiter T. C., Rziha H. J. Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex. J Virol. 1985 Jan;53(1):166–173. doi: 10.1128/jvi.53.1.166-173.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McGinley M. J., Platt K. B. Studies on the ability of a 98-kilodalton pseudorabies virus diagnostic antigen to detect latent infections induced by low-dose exposure to the virus. Am J Vet Res. 1988 Sep;49(9):1489–1493. [PubMed] [Google Scholar]
  13. Mettenleiter T. C., Lukacs N., Rziha H. J. Mapping of the structural gene of pseudorabies virus glycoprotein A and identification of two non-glycosylated precursor polypeptides. J Virol. 1985 Jan;53(1):52–57. doi: 10.1128/jvi.53.1.52-57.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mettenleiter T. C., Lukàcs N., Rziha H. J. Pseudorabies virus avirulent strains fail to express a major glycoprotein. J Virol. 1985 Oct;56(1):307–311. doi: 10.1128/jvi.56.1.307-311.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mettenleiter T. C., Schreurs C., Thiel H. J., Rziha H. J. Variability of pseudorabies virus glycoprotein I expression. Virology. 1987 May;158(1):141–146. doi: 10.1016/0042-6822(87)90247-9. [DOI] [PubMed] [Google Scholar]
  16. Mettenleiter T. C., Schreurs C., Zuckermann F., Ben-Porat T., Kaplan A. S. Role of glycoprotein gIII of pseudorabies virus in virulence. J Virol. 1988 Aug;62(8):2712–2717. doi: 10.1128/jvi.62.8.2712-2717.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rea T. J., Timmins J. G., Long G. W., Post L. E. Mapping and sequence of the gene for the pseudorabies virus glycoprotein which accumulates in the medium of infected cells. J Virol. 1985 Apr;54(1):21–29. doi: 10.1128/jvi.54.1.21-29.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sato K., Tanaka Y., Kurogi H., Tokuhisa S., Numba K., Inaba Y., Matumoto M. Detection of antibody to pseudorabies virus in swine sera by indirect immunoperoxidase plaque staining. J Clin Microbiol. 1988 Jan;26(1):79–81. doi: 10.1128/jcm.26.1.79-81.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wathen M. W., Wathen L. M. Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50. J Virol. 1984 Jul;51(1):57–62. doi: 10.1128/jvi.51.1.57-62.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. van Oirschot J. T. Induction of antibodies to glycoprotein I in pigs exposed to different doses of a mildly virulent strain of Aujeszky's disease virus. Vet Rec. 1988 Jun 18;122(25):599–603. doi: 10.1136/vr.122.25.599. [DOI] [PubMed] [Google Scholar]
  21. van Oirschot J. T., Rziha H. J., Moonen P. J., Pol J. M., van Zaane D. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J Gen Virol. 1986 Jun;67(Pt 6):1179–1182. doi: 10.1099/0022-1317-67-6-1179. [DOI] [PubMed] [Google Scholar]
  22. van Oirschot J. T., de Waal C. A. An ELISA to distinguish between Aujeszky's disease vaccinated and infected pigs. Vet Rec. 1987 Sep 26;121(13):305–306. doi: 10.1136/vr.121.13.305-a. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES